Table 1.
Overview of drugs described to be associated with weight gain [7, 14–21]
| Drug class | Drug name | |
|---|---|---|
| Anticonvulsants | Carbamazepine | |
| Gabapentin | ||
| Pregabalin | ||
| Valproic acid | ||
| Antidepressants | Amitriptyline | Imipramine |
| Citalopram | Maprotiline | |
| Clomipramine | Mirtazapine | |
| Clovoxamine | Nortriptyline | |
| Desipramine | Paroxetine | |
| Doxepin | Phenelzine | |
| Duloxetine | Sertraline | |
| Escitalopram | Tranylcypromine | |
| Fluoxetine | Trimipramine | |
| Fluvoxamine | ||
| Antihistamines | Astemizole | Diphenhydramine |
| Cetirizine | Fexofenadine | |
| Cyproheptadine | (Des)loratadine | |
| Antipsychotics | Aripiprazole | Perphenazine |
| Chlorpromazine | Quetiapine | |
| Clozapine | Risperidone | |
| Fluphenazine | Thioridazine | |
| Haloperidol | Thiothixene | |
| Lithium | Trifluoperazine | |
| Olanzapine | (Ziprasidone)a | |
| Paliperidone | ||
| Corticosteroids | ||
| Diabetes drugs | Insulin | Thiazolidinediones |
| Sulfonylurea | Troglitazone | |
| Chlorpropamide | Pioglitazone | |
| Glibenclamideb | Rosiglitazone | |
| Glimepiride | ||
| Glipizide | ||
| Hypertension | Α-Blockers | Calcium channel |
| drugs | Clonidine | blockers |
| Prazosin | Flunarizine | |
| Terazosin | Nisoldipine | |
| β-Blockers | Centrally acting agents | |
| Atenolol | Methyldopa | |
| Metoprolol | ||
| Propranolol | ||
| Proton pump | Lansoprazole | |
| inhibitors | Omeprazole | |
| Rabeprazole | ||
| Others | Leuprolide acetate | |
| Medroxyprogesterone | ||
| Pizotifen | ||
| Protease inhibitor | ||